With a population of approximately 1.4 billion people, healthcare expenditure of 2.6% of the country’s gross domestic product (GDP), and the presence of several multinational pharmaceutical and biopharmaceutical companies in India are some factors that have led to India being…
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.